Landscapes / Companies
VivaVision Biotech, Inc not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 3
1 in Phase 1
Drugs
3
in active trials · 4 in all
Trials
3 active
8 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | 31 Dec 2026Phase 3 trial completes | |||
| Next date | 31 Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Non-infectious Anterior Uveitis | ||||
| Open drug page | |||||
— |
Phase 3 | 30 Apr 2027Phase 3 trial completes | |||
| Next date | 30 Apr 2027 · Phase 3 trial completes | ||||
| Also tested for | Dry Eye | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Chronic Rhinosinusitis (CRS) | ||||
| Open drug page | |||||
About
- No active trial
- VVN539
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021